Europe's largest drug maker says investment will help meet increasing demand for its adult and pediatric vaccines, including the new cancer shot Cervarix, which is expected to gain regulatory approval in 2007. GlaxoSmithKline has been investing heavily in vaccines business and has been buying companies and technologies.
GlaxoSmithKline in France
Global pharma giant plans to invest 500 million euros in its vaccine production plant in northern France to expand capacity.
May 31, 2007
Recommended
Recommended
Machinery Basics
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Annual Outlook Report: Automation & Robotics
What's in store for CPGs in 2025 and beyond? Packaging World editors explore the survey responses from 118 brand owners, CPG, and FMCG Packaging World readers for its new Annual Outlook Report.
Download
